Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (141-150 of 255) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|April 16, 2024
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)Imran Haider, Darryl P Leong, Martha Louzada, et al.
BMC Medical Informatics and Decision Making|November 29, 2025
Augmenting small tabular health data for training prognostic ensemble machine learning models using generative modelsDan Liu, Samer El Kababji, Nicholas Mitsakakis, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2010
Expression of EGFR, HER-2/neu and KIT in germ cell tumoursIgnacio Durán, Adelaida García-Velasco, Claudio Ballestín, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combinationCarol A Townsley, Gregory R Pond, Amit M Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trialJennifer J Knox, David Hedley, Amit Oza, et al.
The Annals of Pharmacotherapy|September 11, 2008
Medication reconciliation at hospital discharge: evaluating discrepanciesJacqueline D Wong, Jana M Bajcar, Gary G Wong, et al.
Clinical Lung Cancer|November 2, 2015
A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung CancerAnand Swaminath, James R Wright, Theodoros K Tsakiridis, et al.
Clinical Colorectal Cancer|July 16, 2008
Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancerWinson Y Cheung, Gregory R Pond, Mark Rother, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment ToxicitiesDoris Howell, Gregory R Pond, Denise Bryant-Lukosius, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2022
Lack of cognitive impairment in long-term survivors of colorectal cancerJanette L Vardy, Gregory R Pond, Lucette A Cysique, et al.
Pageof 26

Showing results (141-150 of 255) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|April 16, 2024
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)Imran Haider, Darryl P Leong, Martha Louzada, et al.
BMC Medical Informatics and Decision Making|November 29, 2025
Augmenting small tabular health data for training prognostic ensemble machine learning models using generative modelsDan Liu, Samer El Kababji, Nicholas Mitsakakis, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2010
Expression of EGFR, HER-2/neu and KIT in germ cell tumoursIgnacio Durán, Adelaida García-Velasco, Claudio Ballestín, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combinationCarol A Townsley, Gregory R Pond, Amit M Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trialJennifer J Knox, David Hedley, Amit Oza, et al.
The Annals of Pharmacotherapy|September 11, 2008
Medication reconciliation at hospital discharge: evaluating discrepanciesJacqueline D Wong, Jana M Bajcar, Gary G Wong, et al.
Clinical Lung Cancer|November 2, 2015
A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung CancerAnand Swaminath, James R Wright, Theodoros K Tsakiridis, et al.
Clinical Colorectal Cancer|July 16, 2008
Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancerWinson Y Cheung, Gregory R Pond, Mark Rother, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment ToxicitiesDoris Howell, Gregory R Pond, Denise Bryant-Lukosius, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2022
Lack of cognitive impairment in long-term survivors of colorectal cancerJanette L Vardy, Gregory R Pond, Lucette A Cysique, et al.
Pageof 26